UNSPSC 51382804: Clofezone dihydrate

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H20N2O2.C14H21ClN2O2.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TPT3MH65LD, chemically known as acetamide, 2-(4-chlorophenoxy)-n-(2-(diethylamino)ethyl)-, compd. with 4-butyl-1,2-diphenyl-3,5-pyrazolidinedione, hydrate (1:1:2), but more generally known as clofezone dihydrate, which bears US NIH Compound Identifier 6443874.

European Medicines Agency schedules clofezone dihydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06705MIG. Most nations, for tariff purposes, schedule clofezone dihydrate under HS 29331990. SMILES: CCCCC1C(=O)N(N(C1=O)C2CCCCC2)C3CCCCC3.CCN(CC)CCNC(=O)COC1CCC(CC1)CL.O.O.

UNSPSC 51382804 Clofezone dihydrate is a Commodity code that appears in state and local procurement records but does not match the work actually being solicited under it. Recent opportunities tagged to this code involve procurement of naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals and OTC products, and direct-to-manufacturer prescription program services — none of which involve clofezone dihydrate as a named product line. The code shows minimal relevant recent activity, and the mismatch between the code's nominal scope and the actual pharmaceutical and drug-management services being purchased suggests either a cataloging error in the source records or that clofezone dihydrate procurement through state and local channels is not currently active.

The three most recent opportunities tagged to this code span different issuing bodies and procurement approaches. Seminole County, Florida issued an IFB (Solicitation Number IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building. The Texas Health and Human Services Commission posted an RFI (HHS0017013, April 3, 2026) gathering vendor intelligence on direct-to-manufacturer prescription programs to support self-insured employee health plans and state agencies. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC, with contract effectiveness July 1, 2026 and participation from Oregon. Activity appears concentrated in Florida and the upper Midwest cooperative purchasing vehicle, with Texas involvement in market-intelligence work. No recent opportunities directly solicit clofezone dihydrate.